In conclusion, comprehensive metabolic phenotyping of mice harboring the Crebrf R458Q variant revealed only limited effects of the mutation, which did not reproduce either the increased obesity or decreased diabetes risk reported in human variant carriers. Here, CREBRF is linked to obesity disorder.